questionsmedicales.fr
Phénomènes microbiologiques
Phénomènes physiologiques viraux
Réplication virale
Activation virale
Activation virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Diagnostic
Infections virales
Tests de diagnostic
Virus
Symptômes
Infections virales
Biopsie
Infections virales
Symptômes
5
Symptômes
Infections virales
Complications
Infections virales
Symptômes
Maladies infectieuses
Prévention
5
Hygiène
Infections virales
Masques
Prévention des maladies
Voyages
Infections virales
Comportements à risque
Infections virales
Traitements
5
Traitement antiviral
Infections virales
Antibiotiques
Infections virales
Vaccins
Prévention des maladies
Complications
5
Complications
Infections virales
Maladies chroniques
Infections virales
Complications
État de santé
Gestion des complications
Infections virales
Facteurs de risque
5
Facteurs de risque
Infections virales
Maladies chroniques
Infections virales
Mode de vie
Infections virales
Stress
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Activation virale : Questions médicales les plus fréquentes",
"headline": "Activation virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Activation virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-12",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Activation virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Réplication virale",
"url": "https://questionsmedicales.fr/mesh/D014779",
"about": {
"@type": "MedicalCondition",
"name": "Réplication virale",
"code": {
"@type": "MedicalCode",
"code": "D014779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G06.920.925"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Activation virale",
"alternateName": "Virus Activation",
"code": {
"@type": "MedicalCode",
"code": "D014775",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duncan R Smith",
"url": "https://questionsmedicales.fr/author/Duncan%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Atitaya Hitakarun",
"url": "https://questionsmedicales.fr/author/Atitaya%20Hitakarun",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Ryosuke Morimoto",
"url": "https://questionsmedicales.fr/author/Ryosuke%20Morimoto",
"affiliation": {
"@type": "Organization",
"name": "Department of Health and Nutrition, Faculty of Human Life Science, Shikoku University, Tokushima 771-1192, Japan."
}
},
{
"@type": "Person",
"name": "Yuji Isegawa",
"url": "https://questionsmedicales.fr/author/Yuji%20Isegawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka 599-8531, Japan."
}
},
{
"@type": "Person",
"name": "Janejira Jaratsittisin",
"url": "https://questionsmedicales.fr/author/Janejira%20Jaratsittisin",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The TGFβ Induced MicroRNAome of the Trabecular Meshwork.",
"datePublished": "2024-06-19",
"url": "https://questionsmedicales.fr/article/38920689",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells13121060"
}
},
{
"@type": "ScholarlyArticle",
"name": "Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork.",
"datePublished": "2023-06-28",
"url": "https://questionsmedicales.fr/article/37391006",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejphar.2023.175882"
}
},
{
"@type": "ScholarlyArticle",
"name": "TGFβ2 Regulates Human Trabecular Meshwork Cell Contractility",
"datePublished": "2022-05-19",
"url": "https://questionsmedicales.fr/article/35481448",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/02713683.2022.2071943"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of trabecular meshwork height with steroid-induced ocular hypertension.",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37277443",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-36329-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of extracellular matrix deposited by segmental trabecular meshwork cells.",
"datePublished": "2023-07-26",
"url": "https://questionsmedicales.fr/article/37506755",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.exer.2023.109605"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008827"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques viraux",
"item": "https://questionsmedicales.fr/mesh/D018406"
},
{
"@type": "ListItem",
"position": 4,
"name": "Réplication virale",
"item": "https://questionsmedicales.fr/mesh/D014779"
},
{
"@type": "ListItem",
"position": 5,
"name": "Activation virale",
"item": "https://questionsmedicales.fr/mesh/D014775"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Activation virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Activation virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Activation virale",
"description": "Comment diagnostiquer une activation virale ?\nQuels tests sont utilisés pour détecter les virus activés ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on détecter un virus inactif ?\nLes biopsies sont-elles utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Trabecular+Meshwork&page=1#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Activation virale",
"description": "Quels sont les symptômes d'une activation virale ?\nLes symptômes varient-ils selon le virus ?\nL'activation virale cause-t-elle des complications ?\nLes symptômes apparaissent-ils rapidement ?\nPeut-on avoir des symptômes sans activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Trabecular+Meshwork&page=1#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Activation virale",
"description": "Comment prévenir l'activation virale ?\nLe lavage des mains aide-t-il à prévenir les infections ?\nLes masques protègent-ils contre les virus ?\nLes voyages augmentent-ils le risque d'activation virale ?\nLes comportements à risque augmentent-ils l'activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Trabecular+Meshwork&page=1#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Activation virale",
"description": "Quels traitements existent pour l'activation virale ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nLes vaccins aident-ils à prévenir l'activation virale ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Trabecular+Meshwork&page=1#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Activation virale",
"description": "Quelles sont les complications possibles d'une activation virale ?\nL'activation virale peut-elle entraîner des maladies chroniques ?\nLes complications sont-elles prévisibles ?\nLes enfants sont-ils plus à risque de complications ?\nComment gérer les complications d'une activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Trabecular+Meshwork&page=1#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Activation virale",
"description": "Quels sont les facteurs de risque d'activation virale ?\nL'âge influence-t-il le risque d'activation virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie affecte-t-il le risque d'activation virale ?\nLe stress psychologique influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Trabecular+Meshwork&page=1#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activation virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des cultures virales peuvent confirmer l'activation."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les virus activés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les sérologies sont couramment utilisés pour détecter les virus."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent souvent vers une activation virale."
}
},
{
"@type": "Question",
"name": "Peut-on détecter un virus inactif ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les tests ne détectent que les virus actifs ou en phase de réplication."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à identifier des infections virales localisées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une activation virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques et variés."
}
},
{
"@type": "Question",
"name": "L'activation virale cause-t-elle des complications ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des complications graves comme des pneumonies ou des encéphalites."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent apparaître rapidement ou après une période d'incubation prolongée."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans activation virale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres maladies peuvent provoquer des symptômes similaires sans activation virale."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'activation virale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène et l'évitement des contacts sont essentiels."
}
},
{
"@type": "Question",
"name": "Le lavage des mains aide-t-il à prévenir les infections ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon lavage des mains réduit le risque de transmission virale."
}
},
{
"@type": "Question",
"name": "Les masques protègent-ils contre les virus ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques peuvent réduire la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'activation virale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les comportements à risque augmentent-ils l'activation virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des comportements comme le partage d'aiguilles augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'activation virale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les immunomodulateurs et les soins de soutien sont utilisés."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Les vaccins aident-ils à prévenir l'activation virale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent prévenir certaines infections virales et leur activation."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale, réduisant ainsi la charge virale dans l'organisme."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque virus peut nécessiter un traitement spécifique adapté."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une activation virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, l'encéphalite ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'activation virale peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent provoquer des maladies chroniques comme l'hépatite."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé de l'hôte."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables à certaines complications virales."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications d'une activation virale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des traitements appropriés sont essentiels pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'activation virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le stress et les voyages fréquents augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'activation virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et les jeunes enfants sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou le VIH augmentent le risque d'activation virale."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque d'activation virale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'activation virale."
}
},
{
"@type": "Question",
"name": "Le stress psychologique influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
4 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Department of Health and Nutrition, Faculty of Human Life Science, Shikoku University, Tokushima 771-1192, Japan.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka 599-8531, Japan.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, 12120, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore. Electronic address: miccjh@nus.edu.sg.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy. Electronic address: david.lembo@unito.it.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Centre for Global Health Research, University of Edinburgh, Edinburgh, UK.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China; Institute of Comparative Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Animal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China.
Publications dans "Activation virale" :
Primary open-angle glaucoma (POAG) is a progressive optic neuropathy with a complex, multifactorial aetiology. Raised intraocular pressure (IOP) is the most important clinically modifiable risk factor...
Glaucoma is a chronic and progressive neurodegenerative disease characterized by the loss of retinal ganglion cells and visual field defects, and currently affects around 1% of the world's population....
Transforming growth factor-beta 2 (TGFβ2) is a major contributor to the pathologic changes occurring in human trabecular meshwork (HTM) cells in primary open-angle glaucoma (POAG). TGFβ2 activates ext...
Hydrogels were engineered by mixing collagen type I, elastin-like polypeptide, and hyaluronic acid, each containing photoactive functional groups, followed by UV crosslinking. Primary HTM cells were s...
HTM cell morphology and filamentous (F)-actin organization were affected by the underlying culture substrates. TGFβ2 increased HTM cell contractility...
Our data suggest that ERK signaling negatively regulates ROCK-mediated HTM cell contractility. These findings emphasize the critical importance of using tissue-mimetic ECM substrates for investigating...
It is important to identify at-risk patients prior to administering steroid injections to prevent avoidable irreversible blindness inducted by steroid-induced ocular hypertension (SIOH). We aimed to i...
Biophysical and biochemical attributes of the extracellular matrix are major determinants of cell fate in homeostasis and disease. Ocular hypertension and glaucoma are diseases where the trabecular me...
Primary trabecular meshwork cells were isolated from segmental flow regions, and cells were cultured for 4 weeks in the presence or absence or dexamethasone to obtain cell derived matrices (CDM). The ...
Data demonstrate that matrix deposited by cells from low flow regions are stiffer and exhibit a greater number of immature and mature crosslinks, and that these are exacerbated in the presence of ster...
Regardless of a direct correlation between matrix stiffness and crosslinks, we observed distinct differences in the composition and mechanics of the matrices deposited by segmental flow cells. These r...
To evaluate the effect of successive trabecular meshwork photocoagulation (sTMP) on the elevation of intraocular pressure (IOP) to treat or prevent refractory hypotony....
The IOP changes of 15 refractory hypotonic eyes (or estimated to be hypotonic after silicon oil removal) in 15 consecutive patients were retrospectively analysed after sTMP. Fourteen eyes had intraocu...
After sTMP (1 to 125 months of follow-up, 22.87 ± 38.88 months), the average IOP in the 15 eyes was 11.70 ± 3.19mmHg (n = 15), significantly higher than the value before sTMP (8.26 ± 1.93 mmHg, P < 0....
sTMP can significantly increase the IOP with a long-lasting effect and provide an opportunity for the removal of silicone oil despite large-area retinal defects or cyclitic scars in selected eyes....
Glaucoma is the leading cause of irreversible blindness worldwide and is characterized by the progressive degeneration of the optic nerve. Intraocular pressure (IOP), which is considered to be the mai...
Primary open-angle glaucoma is characterized by the progressive degeneration of the optic nerve, with the high intraocular pressure (IOP) being one of the main risk factors. The human trabecular meshw...
The intraocular pressure (IOP)-lowering mechanisms of micropulse laser trabeculoplasty (MLT) remain unclear. The present study was performed to investigate the mechanism of action of MLT, and to deter...
Glaucoma is a complex neurodegenerative disease resulting in progressive optic neuropathy and is a leading cause of irreversible blindness worldwide. Primary open angle glaucoma (POAG) is the predomin...